Meitav Investment House’s VanEck Pharmaceutical ETF PPH Stock Holding History

Meitav Investment House’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,367	Closed	-$106K	–	472
2023 Q2	$106K	Buy	+1,367	New	+$107K	﹤0.01%	389
2022 Q1	–	Sell	-4,895	Closed	-$377K	–	403
2021 Q4	$377K	Hold	4,895	–	–	0.01%	326
2021 Q3	$356K	Hold	4,895	–	–	0.01%	334
2021 Q2	$358K	Hold	4,895	–	–	0.01%	338
2021 Q1	$338	Buy	+4,895	New	+$337K	0.01%	310
2020 Q2	–	Sell	-4,895	Closed	-$266K	–	428
2020 Q1	$266K	Buy	4,895 +1,367	+39%	+$84.2K	0.02%	305
2019 Q4	$226K	Sell	3,528 -1,367	-28%	-$82.4K	0.02%	382
2019 Q3	$278K	Buy	+4,895	New	+$280K	0.02%	352
2019 Q2	–	Sell	-4,895	Closed	-$297K	–	474
2019 Q1	$297K	Sell	4,895 -368,299	-99%	-$21.8M	0.02%	316
2018 Q4	$20.5M	Sell	373,194 -109,085	-23%	-$6.61M	1.27%	23
2018 Q3	$31M	Sell	482,279 -800	-0.2%	-$49.9K	1.51%	19
2018 Q2	$28.4M	Buy	483,079 +152,045	+46%	+$8.81M	1.27%	23
2018 Q1	$18.8M	Sell	331,034 -9,860	-3%	-$589K	0.96%	37
2017 Q4	$20.2M	Buy	+340,894	New	+$19.5M	1.18%	29

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Meitav Investment House's PPH Position: Q3 2023 in Review

Meitav Investment House sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2023, closing a stake of 1,367 shares — an estimated $106K sold.

Meitav Investment House first reported a position in PPH in Q4 2017 and held it in 14 quarters. The position peaked at $31M in Q3 2018. 102 funds tracked by Wall St. Rank hold PPH as of Q3 2023.

Meitav Investment House reported no remaining VanEck Pharmaceutical ETF position as of Q3 2023 after selling out during the quarter.
Meitav Investment House sold 1,367 VanEck Pharmaceutical ETF shares in Q3 2023, an estimated $106K.
Meitav Investment House first reported a position in VanEck Pharmaceutical ETF in Q4 2017 and held it in 14 quarters.
Meitav Investment House's VanEck Pharmaceutical ETF position peaked at $31M in Q3 2018.
102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2023.

Based on Meitav Investment House's 13F filing for Q3 2023, filed 30 Oct 2023.